Acemannan

DB19224InvestigationalSmall molecule

Acemannan is under investigation in clinical trial NCT03250923 (Celagace™ Orarinse Solution for Treatment of Candidiasis).

Mechanism: Pharmacologically active on Histone deacetylase and Toll-like receptor 5
Curator reviewed
Also known as: Acemannan (aloe vera) · Acemannan aloe vera (1300000 mw) · Acemannan aloe vera (1400000 mw) · Aloe acetylated mannan polysaccharide 1300 kda mw · Carrisyn

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Acemannan, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.